New agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide

被引:35
作者
Heifets, L [1 ]
Sanchez, T [1 ]
机构
[1] Natl Jewish Med & Res Ctr, Denver, CO USA
关键词
D O I
10.1128/JCM.38.4.1498-1501.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A new agar medium to perform pyrazinamide (PW) susceptibility testing with Mycobacterium tuberculosis has been developed. This medium has an acidic pH of 6.0 instead of the usual for agar media, pH 6.8, to provide optimal conditions for PZA activity, and it also differs from conventional Middlebrook 7H10/7H11 agar in that animal serum (fetal or calf bovine or fetal equine serum) is used instead of oleic acid-albumin-dextrosecatalase to support good growth of Xi. tuberculosis at the low pH of 6.0. ii critical concentration of 900 or 1,200 mu g of PZA/ml in this medium made it possible to differentiate bem een PZA-susceptible and PZA-resistant clinical isolates. This agar medium has the following advantages compared to a liquid medium: it allows determination of the actual proportion of PZA-resistant bacteria in the isolate and it is simple and inexpensive. In addition, it has the potential of being used for a direct susceptibility test with PW, but this approach will require further confirmation. Further studies to develop critical concentrations of other drugs for this low-pH medium, as welt as to investigate the possibility of cultivation in regular (non-CO2) incubators, are in progress.
引用
收藏
页码:1498 / 1501
页数:4
相关论文
共 12 条
[1]   SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE AND ITS RELATIONSHIP TO PYRAZINAMIDASE ACTIVITY [J].
BUTLER, WR ;
KILBURN, JO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :600-601
[2]   IMPROVED METHOD FOR TESTING SUSCEPTIBILITY OF MYCOBACTERIUM-TUBERCULOSIS TO PYRAZINAMIDE [J].
BUTLER, WR ;
KILBURN, JO .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 16 (06) :1106-1109
[3]  
Heifets L B., 1991, DRUG SUSCEPTIBILITY, P89
[4]  
Heifets LB, 1999, INT J TUBERC LUNG D, V3, P564
[5]   DRUG-RESISTANT TUBERCULOSIS - INCONSISTENT RESULTS OF PYRAZINAMIDE SUSCEPTIBILITY TESTING [J].
HEWLETT, D ;
HORN, DL ;
ALFALLA, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :916-917
[6]   Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test [J].
Miller, MA ;
Thibert, L ;
Desjardins, F ;
Siddiqi, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (01) :84-86
[7]   DETERMINATION OF PYRAZINAMIDE MICS FOR MYCOBACTERIUM-TUBERCULOSIS AT DIFFERENT PHS BY THE RADIOMETRIC METHOD [J].
SALFINGER, M ;
HEIFETS, LB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (07) :1002-1004
[8]   Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus [J].
Scorpio, A ;
Zhang, Y .
NATURE MEDICINE, 1996, 2 (06) :662-667
[9]   Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis [J].
Scorpio, A ;
LindholmLevy, P ;
Heifets, L ;
Gilman, R ;
Siddiqi, S ;
Cynamon, M ;
Zhang, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :540-543
[10]  
SIDDIQI S, 1992, CLIN MICROBIOLOGY PR, P1